BIO vs WSR · rev $651.0M vs P/E 20, rev $160.9M
BIO (BIO) versus Whitestone REIT (WSR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Whitestone REIT (WSR) is a reit - retail company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported WSR revenue for 2025-12-31 was $160.9M. Net income was $49.9M. Revenue was up 293.9% from 2024-12-31 to 2025-12-31. WSR currently screens at market cap $984.4M and trailing P/E 19.7.
BIO currently screens at market cap $0. WSR currently screens at market cap $984.4M and trailing P/E 19.7.
Not investment advice. Open the BIO and WSR stock pages for the full models.
Not investment advice.